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Abstract We examined prevalence of diagnosed autism
spectrum disorder (ASD) and age at diagnosis according to
child’s race/ethnicity and primary household language.
From the 2009–2010 National Survey of Children with
Special Health Care Needs, we identified 2729 3–17-year-
old US children whose parent reported a current ASD diag-
nosis. We compared ASD prevalence, mean diagnosis age,
and percentage with later diagnoses (C5 years) across racial/
ethnic/primary household language groups: non-Hispanic-
white, any language (NHW); non-Hispanic-black, any lan-
guage (NHB); Hispanic-any-race, English (Hispanic-Eng-
lish); and Hispanic-any-race, other language (Hispanic-
Other). We assessed findings by parent-reported ASD
severity level and adjusted for family sociodemographics.
ASD prevalence estimates were 15.3 (NHW), 10.4 (NHB),
14.1 (Hispanic-English), and 5.2 (Hispanic-Other) per 1000
children. Mean diagnosis age was comparable across racial/
ethnic/language groups for 3–4-year-olds. For 5–17-year-
olds, diagnosis age varied by race/ethnicity/language and
also by ASD severity. In this group, NHW children with
mild/moderate ASD had a significantly higher proportion
(50.8 %) of later diagnoses than NHB (33.5 %) or Hispanic-
Other children (18.0 %). However, NHW children with
severe ASD had a comparable or lower (albeit non-sig-
nificant) proportion (16.4 %) of later diagnoses than NHB
(37.8 %), Hispanic-English (30.8 %), and Hispanic-Other
children (12.0 %). While NHW children have comparable
ASD prevalence and diagnosis age distributions as Hispanic-
English children, they have both higher prevalence and
proportion of later diagnoses than NHB and Hispanic-Other
children. The diagnosis age findings were limited to
mild/moderate cases only. Thus, the prevalence disparity
might be primarily driven by under-representation (poten-
tially under-identification) of older children with
mild/moderate ASD in the two minority groups.
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Introduction
Autism spectrum disorder (ASD) is characterized by im-
pairments in social interactions and communication and
restricted, repetitive, and stereotyped patterns of behavior
[1]. ASD symptoms are often noted early in life and di-
agnosis can occur as early as 2 years of age [1, 2]. Previous
studies suggest early diagnosis is important because early
interventions may be more effective [3–6]. Recent studies
suggest that ASD prevalence has increased [7–16] and
ASD diagnosis age has decreased in US children [7, 9, 17–
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20]; however, racial/ethnic differences remain [7–9, 11, 12,
15, 17–29].
The most recent US population-based ASD estimates
from both the 2010 Autism and Developmental Disabilities
Monitoring (ADDM) Network (1.5 %) and the 2011–2012
National Survey of Children’s Health (NSCH) (2 %) repre-
sented substantial increases from prevalence estimates just a
few years earlier [7, 9]. Additionally, both ADDM and
NSCH studies have shown that non-Hispanic-white children
had higher ASD prevalence than non-Hispanic-black and
Hispanic children [8, 11], and an NSCH study documented
that Hispanic children with foreign-born parents had a sub-
stantially lower prevalence than Hispanic children with US-
born parents and all non-Hispanic-white children [26].
Several studies suggest that ASD diagnosis age has been
decreasing, overall, among US children. While in the 2002
ADDM, the median age at first diagnosis was 5.7 years, the
mean age in 2006 was 4.4 years [15, 17]. Likewise, the
mean age of receipt of ASD services from the California
Department of Developmental Services decreased from 6.9
to 3.3 years from 1987 to 1994 [18]. Previous studies also
reported that, as expected, diagnosis age varies by ASD
subtype, with notably higher diagnosis ages for Asperger’s
disorder than autistic disorder [7, 20], and that later ASD
diagnosis age is associated with non-Hispanic-black and
Hispanic race/ethnicity [24, 29], low income [20, 24], lack
of awareness among healthcare professionals and parents
[21, 23], certain clinical presentations [12], and physician
behaviors in screening practices [19, 20, 22, 27, 28].
Beyond general studies of predictive factors, there have
been few in-depth population-based studies of ASD diagnosis
age by child’s race/ethnicity. Past studies were limited by
small sample size and have not accounted for variation within
the Hispanic subgroup. In this study, we compare ASD di-
agnosis age across racial/ethnic groups in a population-based
sample from the 2009–2010 National Survey of Children with
Special Health Care Needs (NS-CSHCN). Additionally, we
study Hispanic children within subgroups based on primary
household language, which was previously found to be closely
correlated with parents’ birthplace and thus, an indicator of the
autism prevalence heterogeneity among Hispanic children
[26]. Within all racial/ethnic groups, we also consider child’s
ASD severity as a potential predictor or modifier of diagnosis
age, and assess the variation of ASD prevalence estimates by
both race/ethnicity and diagnosis age.
Methods
Study Sample
The 2009–2010 NS-CSHCN was a random-digit-dial tele-
phone survey conducted by the National Center for Health
Statistics. Households were the primary sampling units. In
each selected household with children, a parent/guardian was
administered a screening instrument to determine if any chil-
dren had special healthcare needs. Special healthcare needs
were defined as meeting one or more criteria in association
with a long-term health condition: ongoing need for prescrip-
tion medications; need for more medical care, mental health, or
educational services than usual for most same-aged children;
limited abilities in comparison to most same-aged children;
need for special therapy, such as physical, occupational, or
speech therapy; and/or having an emotional, developmental, or
behavioral problem necessitating treatment or counseling [30].
If one child was identified as having special healthcare needs,
s/he was selected to be the subject of a detailed parent/guardian
interview. If more than one child was identified, one was
randomly selected to be the subject of the interview.
The final NS-CSHCN data files include screening data
on 371,617 children. Of these, 40,242 CSHCN were se-
lected and detailed interviews were completed. The overall
response rate was 25.5 %. Most nonresponse occurred due
to no answer or person answering did not identify whether
a child lived in the household; this nonresponse was more
common for cell-phones than for landlines. Among
households known to include a child with special health-
care needs, the interview completion rate was 80.8 % [31].
Of the 40,242 CSHCN with completed interviews, 38,034
were aged 3–17 years. For this analysis, we initially selected
all 3025 CSHCN aged 3–17 years with parent-report of
ASD. We did not include children aged\3 years because
many children with ASDs are not diagnosed earlier [7, 15,
17, 20]. We excluded 296 Asian, Native Hawaiian/Pacific
Islander, and multiple-race children because small sample
sizes in these subgroups precluded race-specific analyses.
Our final sample included 2729 non-Hispanic-white, non-
Hispanic-black, and Hispanic children with ASD.
ASD Ascertainment
ASD was ascertained using two questions: ‘‘Has a doctor or
other health care provider ever told you that [CHILD] had
autism, Asperger’s disorder, pervasive developmental dis-
order, or other autism spectrum disorder?’’ and if YES,
‘‘Does [CHILD] currently have autism or an autism spec-
trum disorder?’’ Children whose parents answered affir-
matively to both questions were classified as having
ASD. Because 23 % of children reported to have a past
ASD diagnosis were not reported to have ASD currently,
this ASD definition might be conservative.
Ascertainment of ASD Diagnosis Age and Severity
Parents of children classified as having ‘‘current’’ ASD
were further asked to describe their child’s autism or ASD
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as either mild, moderate, or severe and were asked their
child’s age at first autism/ASD diagnosis. No further in-
structions were given in regards to assigning the severity
level. We initially analyzed diagnosis age as a continuous
variable and an ordinal variable: 3–4, 5–8, 9–12 and
C13 years. Because of sample size constraints, detailed
analyses related to profile and predictors of diagnosis age
used a dichotomized outcome measure: later diagnosis age
(C5 years, Yes/No). This cut-point was chosen based on
sample size and recent US data indicating mean ASD di-
agnosis age was 4.4 years [17].
Parents’ perceptions of ASD severity were di-
chotomized as severe versus mild/moderate. Mild and
moderate responses were combined because an empiric
assessment indicated they were similarly associated with
diagnosis age. We also assessed a second indicator of
severity, parent-report of intellectual disability (ID) diag-
nosis (analogous question series as ASD).
Race/Ethnicity/Language and Other Variables
of Interest
Our outcome of interest was diagnosis age and the main
risk/predictive factor of interest was race/ethnicity. Four
racial/ethnic and primary household language groups were
created: non-Hispanic-white, any language (NHW); non-
Hispanic-black, any language (NHB); Hispanic-any-race,
English (Hispanic-English); and Hispanic-any-race, other
language (Hispanic-Other).
Other demographic characteristics included child’s age
at survey, child’s sex, highest education of parent/guardian,
household income relative to the federal poverty level, total
number of children in household, type of health insurance,
and family structure. Additionally, we assessed several co-
occurring health conditions previously reported to be more
common in children with ASDs: difficulty with repeated
chronic physical pain (including headaches), asthma,
epilepsy/other seizure disorder, allergies (any type), food
allergies, and Attention-Deficit/Hyperactivity Disorder
(ADD/ADHD) [32]. We did not examine several other co-
occurring conditions (e.g. diabetes) due to sample size
constraints.
Statistical Analyses
Within each race/ethnicity/language group, ASD preva-
lence was estimated as the number of CSHCN who cur-
rently had ASD, divided by the total number of 3–17-year-
old children who were included in the initial household
screening sample. Thus, the denominator included both
CSHCN and children without special healthcare needs.
Because children first classified as having special health-
care needs were the subjects of the detailed interviews,
information on a child’s ASD diagnosis was only ascer-
tained on these selected children. Although prevalence
estimates were weighted to be representative of the US
population of non-institutionalized children aged
3–17 years, some ASD cases might have been missed if a
parent did not first indicate a special healthcare need.
However, independent assessments of data from other na-
tionally representative surveys indicate that 94 % of chil-
dren whose parents respond affirmatively to the ASD
questions are classified as CSHCN [33]. In addition to race/
ethnicity/language group, we calculated ASD prevalence
within strata based on timing (age) of ASD diagnosis and
severity.
We assessed mean and percentage distribution of ASD
diagnosis age within strata defined based on both race/
ethnicity/language and child’s age at survey. The latter
stratification was needed to control for birth-cohort-related
factors or differential time frames in which a child could
have received a diagnosis.
The remainder of analyses were limited to children aged
5–17 years because younger children, by definition, did not
have a later ASD diagnosis. We assessed ASD severity and
sociodemographic factors as potential predictors of later
diagnoses, and the profile of children with earlier versus later
diagnoses in terms of their co-occurring health conditions.
In various analyses, we used t tests and Chi square tests
to compare group differences in means and percentage
distributions, respectively. We calculated unadjusted odds
ratios (ORs) with 95 % confidence intervals (CIs) in which
the odds of later diagnoses within each race/ethnicity/lan-
guage group were compared to those for NHWs. We
similarly calculated stratum-specific ORs. We tested for
significant interactions between race/ethnicity/language
and each severity indicator using likelihood ratio tests.
Because of sample size constraints in some subgroups,
we calculated relative standard errors (RSE, standard error/
prevalence estimate 9100) for each estimate and indicate
those that have a moderately high variability (30–50 %) or
high variability ([50–60 %). We do not present estimates
where RSE is[60 %.
Adjusted odds ratios (aORs) for associations between
later ASD diagnoses and sociodemographic variables were
computed using multivariable logistic regression. We
constructed two models: the first model included race/
ethnicity/language and the aforementioned other sociode-
mographic factors as independent variables; the second
model additionally included ASD severity and an interac-
tion term to examine the potential effect modification be-
tween race/ethnicity/language and ASD severity level. We
additionally evaluated the first model stratified on both
ASD severity and co-occurring ID.
All estimates were weighted to obtain nationally repre-
sentative estimates [31]. We used multiply-imputed data
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for child’s race/ethnicity, primary household language,
highest education of parents/guardians, and household in-
come [33]. Analyses were conducted using SAS-callable
SUDAAN (Research Triangle Institute, Research Triangle
Park, NC) to account for the complex sampling design.
Human subjects review was not required for this study
since this was a secondary analysis of de-identified datasets.
Results
Characteristics of CSHCN with ASD
In this nationally representative study, the estimated
prevalence of CSHCN with diagnosed ASD was 15.3 per
1000 NHW children aged 3–17 years (Fig. 1). In compar-
ison, Hispanic-English children had a similar estimate,
while NHB and Hispanic-Other children had significantly
lower ASD estimates.
Among CSHCN with ASD, distributions of demo-
graphic characteristics varied across race/ethnicity/lan-
guage groups (Table 1). Age at survey was markedly
younger and household education and income levels were
notably lower for Hispanic-Other children compared to
other groups. Hispanic-Other children had the highest
proportion of no health insurance and NHB children had
the highest proportion of public-only health insurance.
While most children lived in two-parent biological/adopted
households, 40 % of NHB children lived in single-mother-
households, twice that of all other groups. Neither child sex
nor number of children in the household varied sig-
nificantly across race/ethnicity/language groups; nor did
either of the ASD severity indicators (although non-sig-
nificant variation was noted).
Distribution of Diagnosis Age by Race/Ethnicity/
Language
Within each race/ethnicity/language group except Hispan-
ic-Other, diagnosis age increased with each successive
increase in child’s age at survey (Table 2). Among 3–4-
year-olds, mean ASD diagnosis age was comparable across
race/ethnicity/language groups (range 2.3–2.5). Among
5–8-year-olds, there was only slight variation in diagnosis
age, although mean age for Hispanic-English children (2.9)
was significantly lower than that for NHWs (3.5). Among
children aged 9–12 and C13 years, mean diagnosis age was
comparable for NHW, NHB, and Hispanic-English chil-
dren (overall means 5.0 and 6.3 for 9–12 and C13 years,
respectively), while Hispanic-Other children had sig-
nificantly lower mean diagnosis ages (2.9 and 3.7,
respectively).
Likewise, among children aged 5–8, 9–12, and
C13 years, the percentage distributions of the ordinal cate-
gories of ASD diagnosis age were fairly similar for NHW,
NHB, and Hispanic-English children (Table 3). However,
89 % of Hispanic-Other children aged 9–12 years had an
earlier diagnosis compared to 50 % of NHW children, and
Hispanic-Other children aged C13 years showed a trend
(albeit non-significant) toward younger diagnosis age than
NHW children (P = 0.10).
Predictors of Later Diagnosis Age, Race/Ethnicity/
Language and ASD Severity
Overall, NHW children aged 5–17 years had the highest
proportion of later diagnoses while Hispanic-Other had the
lowest (Table 4). However, these findings varied by ASD
severity. Likelihood ratio tests testing for interactions be-
tween race/ethnicity/language and both severity indicators,
parent-reported severity and co-occurring ID, were sig-
nificant. Stratified analyses illustrated the magnitude of
these effect modifications. Among children whose parents
perceived their severity level as mild/moderate, a higher
proportion (50.8 %) of NHW children had later diagnoses
than NHB (33.5 %) or Hispanic-Other children (18.0 %).
However, among children with severe ASD, a lower (albeit
non-significant) proportion of NHW children (16.4 %) had
later diagnoses than NHB (37.8 %), and Hispanic-English
(30.8 %) children; the proportions appeared fairly compa-
rable for NHW and Hispanic-Other (12.0 %) children. A
similar pattern was seen when comparing children with or
without co-occurring ID. Overall, the associations between
race/ethnicity/language and later diagnoses were not sub-
stantially impacted by adjustment for sociodemographic
factors. However, the difference in odds of later diagnosis
for NHB children with severe ASD increased slightly and
was statistically significant.
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Fig. 1 Estimated prevalence of CSHCN aged 3–17 years with ASD
by race/ethnicity/language, United States, 2009–2010. Racial/ethnic
and primary household language groups were categorized as: non-
Hispanic-white, any language (NHW); non-Hispanic-black, any
language (NHB); Hispanic-any race, English (Hispanic-English);
and Hispanic-any race, other language (Hispanic-Other). aPrevalence
estimate is significantly different from NHW children
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Predictors of Later Diagnosis Age, Sociodemographic
Factors
In addition to associations with race/ethnicity/language, the
findings from the multivariable models also indicated that
children living in two-parent stepfamily households, single-
mother-households, or households with other structures were
more likely to have a later diagnosis than those living with two
biological/adoptive parents (aOR 1.83, 95 % CI 1.35–2.48),
and that children living in households with incomes\200 %
Table 1 Percentage distributiona of selected demographic characteristics of CSHCN aged 3–17 years with ASD by race/ethnicity/language,
United States, 2009–2010
Total
(n = 2729)
(%)
NHW
(n = 2192)
(%)
NHB
(n = 208)
(%)
Hispanic-English
(n = 256)
(%)
Hispanic-Other
(n = 73)
(%)
P valueb
Age (years)
3–5 17.2 13.4 23.7 21.5 45.5 \0.005
6–10 38.7 38.1 39.7 46.1 24.7
11–17 44.1 48.5 36.6 32.4 29.9
Sex
Male 80.3 79.8 81.7 81.0 83.5 0.91
Female 19.7 20.2 18.4 19.0 16.5c
Highest education household member
\High school 8.3 5.4 10.9 15.3 27.1 \0.005
High school 16.0 14.1 19.8 17.1 31.5
[High school 75.7 80.5 69.3 67.6 41.4
Household income
B200 % Federal poverty level 40.4 34.9 57.6 42.7 73.0 \0.005
[200 % Federal poverty level 59.6 65.1 42.5 57.4 27.0c
Total number of children in household
1 25.3 24.8 28.9 22.5 31.1 0.40
2 41.5 42.6 42.3 40.3 27.1
3? 33.2 32.6 28.8 37.3 41.8
Health insurance
Private/both/other 66.1 72.3 41.8 61.1 47.1 \0.005
Public 31.2 25.9 52.5 35.7 45.0
Uninsured 2.7 1.8 5.7c 3.2d 7.9d
Family structure
Two-parent biological/adopted 63.0 67.0 44.1 56.3 68.9 \0.005
Two-parent stepfamily 8.4 7.8 8.6 13.0 –e
Single mother, no father present 20.4 16.7 40.2 22.0 20.8
Other 8.3 8.5 7.1c 8.7b 6.9d
ASD severity
Mild 49.9 50.3 44.4 51.5 53.3 0.23
Moderate 35.9 36.0 34.5 40.4 25.9
Severe 14.2 13.7 21.1 8.1c 20.7c
Intellectual disability
Yes 26.5 23.8 34.0 31.8 33.6 0.10
No 73.5 76.3 66.0 68.2 66.4
a Weighted percentages
b Chi square test of independence between each characteristic and race/ethnicity/language
c Relative standard error (RSE) is 30–50 %
d RSE is[50–60 % indicating the variance is large and thus estimate should be interpreted cautiously
e Estimate not presented if RSE was[60 %
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of the federal poverty level were more likely to have a later
diagnosis than those from higher income households (aOR
1.44, 95 % CI 1.02–2.03). Neither household members’
education levels nor child’s type of health insurance were
significantly associated with later diagnosis (data not shown).
Predictors of Later Diagnosis Age, Co-occurring Health
Conditions
NHW and NHB children with a later ASD diagnosis were
more likely to have co-occurring ADD/ADHD than NHW
and NHB children with an earlier diagnosis (Table 5).
NHB children with a later diagnosis were also more likely
to have difficulty with repeated chronic physical pain.
While the reasons varied for this condition, 16 % of NHB
children with repeated chronic physical pain also reported
as having sickle cell disease.
Variation in ASD Prevalence by Race/Ethnicity/
Language and ASD Severity
Given the findings observed in our analyses of diagnosis
age, we further assessed ASD prevalence within subgroups
based on diagnosis age and severity (Fig. 2). Among
children aged 5–17 years, the prevalence differential be-
tween NHW and Hispanic-Other children was much larger
for mild/moderate ASD (13.9 vs. 3.0) than severe ASD (2.4
vs. 1.1). Likewise, the prevalence differential between
NHW and NHB children was notable for mild/moderate
ASD (13.9 vs. 8.4), while prevalence of severe ASD was
Table 3 Percentage distributiona of age at first diagnosis by race/ethnicity/language and age at survey in children aged 3–17 years with ASD,
United States, 2009–2010
Age at first diagnosis (years) NHW (%) NHB (%) Hispanic-English (%) Hispanic-Other (%)
Age at survey: 5–8 years
3–4 74.7 74.9 82.4 84.7
5–8 25.3 25.1 17.6c 15.3d
Age at survey: 9–12 years
3–4 49.9 55.6 48.3 88.9b
5–8 38.1 31.1 37.0 –e
9–12 12.0 13.3c 14.6c 0.0b
Age at survey: C13 years
3–4 40.6 57.3 34.5 61.5c
5–8 27.9 13.2c 37.8 32.3d
9–12 23.0 21.9c 13.8d –e
C13 8.5 7.5d 13.8d 0.0
Age at survey: 5–17 years (n = 2498)
3–4 54.0 64.7 58.2 79.0b
5–8 31.1 23.6 29.9 19.2b,c
9–12 12.1 9.7 8.9c –e
C13 2.8 2.0d 3.0c 0.0b
a Weighted percentages
b Two-tailed z test comparing diagnosis age distribution within each race/ethnicity/language group to diagnosis age distribution among NHW;
significant difference between Hispanic-Other and NHW children (P\ 0.05)
c Relative standard error (RSE) is 30–50 %
d RSE is[50–60 % indicating the variance is large and thus should be interpreted cautiously
e Estimate not presented if RSE was[60 %
Table 2 Mean age at first diagnosis within each race/ethnicity/lan-
guage and age at survey group of children aged 3–17 years with ASD,
United States, 2009–2010
Age at survey (years)
3–4 5–8 9–12 C13 5–17
Mean age at first diagnosis (years)
Overall 2.4 3.4 5.0 6.3 4.9
NHW (n = 2182) 2.3 3.5 5.0 6.5 5.1
NHB (n = 205) 2.4 3.5 5.1 5.8 4.6
Hispanic-English (n = 251) 2.3 2.9a 5.3 6.8 4.7
Hispanic-Other (n = 71) 2.5 3.3 2.9b 3.7b 3.3b
a t test comparing mean diagnosis age in each race/ethnicity/language
group within each age at survey group to NHW children; significant
difference between Hispanic-English and NHW children (P\ 0.05)
b t test comparing mean diagnosis age in each race/ethnicity/language
group within each age at survey group to NHW children; significant
difference between Hispanic-Other and NHW children (P\ 0.05)
1692 Matern Child Health J (2015) 19:1687–1697
123
comparable (2.4 vs. 2.5). The prevalence variation across
race/ethnicity/language groups was also greater for those
with later versus earlier diagnoses and was particularly
prominent for those with later diagnoses of mild/moderate
ASD.
Discussion
These findings demonstrate that NHW children have higher
reported ASD prevalence estimates and a higher proportion
of later diagnoses than NHB and Hispanic-Other children.
However, the variation in diagnosis age was limited to
children with mild/moderate ASD. Additionally, our de-
tailed assessment of prevalence estimates suggests that
while Hispanic-Other children have much lower levels of
ASD ascertainment than NHW children at all ages, the
prevalence difference is particularly striking for diagnoses
of mild/moderate cases at later ages. Further, while the
prevalence of earlier-diagnosed ASD is comparable be-
tween NHW and NHB children, the prevalence of later-
diagnosed mild/moderate ASD is again much higher for
NHW than NHB children. Thus, the prevalence disparity
between NHWs and two minority groups appears to be
primarily driven by under-representation (potentially un-
der-identification) of older children with mild/moderate
ASD in the two minority groups.
The pattern of our race/ethnicity-specific prevalence find-
ings are in line with previous studies [7, 9], and our findings for
Hispanic children confirm a previous study that found lower
ASD prevalence in Hispanic children with foreign-born par-
ents than Hispanic children with US-born parents [26].
However, contrary to some previous studies on racial/
ethnic differences in diagnosis age [24, 29], NHB and
Hispanic children in our study had a comparable or lower
diagnosis age than NHW children. Differences in study
results might be explained by methodological differences.
While we subdivided Hispanic children based on language,
previous studies of diagnosis age treated Hispanic children
as a single homogenous group. We also had a much larger
sample size and assessed a wider age range than previous
studies. We examined later diagnoses in the context of
ASD severity while some previous studies did not. How-
ever, studies have noted that children with earlier diagnoses
were more likely to have prominent clinical characteristics
such as language regression [20, 29], which is consistent
Table 4 Association between race/ethnicity/language and later diagnosis of ASD based on ASD severity indicators among CSHCN aged 5–17
years with ASD, United States, 2009–2010a
Later
diagnosisb
(%)
Unadjusted
OR
(95 % CI)
Adjusted ORc
(95 % CI)
Later
diagnosisb
(%)
Unadjusted OR
(95 % CI)
Adjusted ORc
95 % CI
Overall
NHW 46.0 1.00 (Referent) 1.00 (Referent)
NHB 35.3 0.64 (0.41–1.01) 0.61 (0.39–0.96)
Hispanic-
English
41.8 0.84 (0.54–1.32) 0.77 (0.49–1.19)
Hispanic-Other 21.0 0.31 (0.14–0.68) 0.33 (0.14–0.76)
ASD severity: mild/moderate ASD severity: severe
NHW 50.8 1.00 (Referent) 1.00 (Referent) NHW 16.4 1.00 (Referent) 1.00 (Referent)
NHB 33.5 0.49 (0.30–0.79) 0.42 (0.26–0.69) NHB 37.8 3.10 (0.90–10.71) 3.88 (1.11–13.57)
Hispanic-
English
43.5 0.75 (0.47–1.19) 0.63 (0.40–0.99) Hispanic-
English
30.8 2.27 (0.38–13.67) 1.97 (0.39–9.96)
Hispanic-Other 18.0 0.21 (0.09–0.52) 0.20 (0.07–0.53) Hispanic-Other 12.0 0.70 (0.12–4.19) 1.07 (0.18–6.54)
ASD without intellectual disability ASD with intellectual disability
NHW 49.9 1.00 (Referent) 1.00 (Referent) NHW 34.0 1.00 (Referent) 1.00 (Referent)
NHB 33.3 0.50 (0.29–0.87) 0.45 (0.26–0.79) NHB 39.0 1.41 (0.63–3.16) 1.54 (0.68–3.49)
Hispanic-
English
40.9 0.69 (0.41–1.17) 0.64 (0.38–1.06) Hispanic-
English
44.1 1.70 (0.70–4.13) 1.33 (0.58–3.05)
Hispanic-Other 26.6 0.36 (0.14–0.94) 0.37 (0.14–1.02) Hispanic-Other 13.4 0.30 (0.09–1.08) 0.30 (0.07–1.19)
a Weighted percentages
b Later diagnosis is defined as those diagnosed at age C5 years
c Model adjusts for education, income, health insurance, family structure, and race/ethnicity/language
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with our finding of lower diagnosis ages among children
reported to have severe ASD. Additionally, a US popula-
tion-based study reported that children identified with ASD
at later ages had fewer ASD characteristics, overall,
documented in their school and health records than chil-
dren identified earlier and children with certain types of
ASD features, such as impairments in non-verbal com-
munication, were less likely to have later diagnoses [12].
Table 5 Differences in co-occurring health conditions in children aged 5–17 years with ASD based on age at diagnosis and race/ethnicity/
language, United States, 2009–2010a,b
Age at diagnosis NHW (%) NHB (%) Hispanic-English
(%)
Hispanic-Other (%)
\5 years C5 years \5 years C5 years \5 years C5 years \5 years C5 years
n = 1000 n = 1030 n = 112 n = 73 n = 135 n = 95 n = 36 n = 17
Difficulty with repeated chronic physical pain,
including headaches
28.1 32.3 17.7c,f 47.6f 33.0 48.0 7.4c 8.4d
Asthma 20.0 23.8 29.7 35.4 27.1 37.3 14.7d 19.6d
Epilepsy or other seizure disorder 10.5 8.8 9.7c 9.2d 10.7c 14.1c –e –e
Allergies (any type) 48.5 49.0 44.1 64.1 42.7 56.1 27.0c 28.7c
Food allergies 30.8 24.8 35.3c 23.9c 51.5 12.2d –e 0.0
ADD or ADHD 43.1g 71.6g 31.8g 61.0g 41.6 55.3 57.9 74.2
a Weighted percentages
b These are children with a parent report of ever being told by a doctor or other health care provider that their child had a specific health
condition
c Relative standard error (RSE) is 30–50 %
d RSE is[50–60 % indicating the variance is large and thus should be interpreted cautiously
e Estimate not presented if RSE was[60 %
f Significant difference in difficulty with repeated chronic physical pain, including headaches between NHB children with earlier diagnosis age
(\5 years) and NHB children with later diagnosis age (C5 years)
g Significant difference in ADD or ADHD between NHW children with earlier diagnosis age and NHW children with later diagnosis age; and
significant difference in ADD or ADHD between NHB children with earlier diagnosis age and NHB children with later diagnosis age
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Fig. 2 Estimated prevalence of ASD by race/ethnicity/language,
parent-assessed severity, and age at diagnosis among children aged
5–17 years at survey, United States, 2009–2010. Weighted prevalence
estimates are per 1000 non-institutionalized children in the US
population. aAge at diagnosis is \5 years. bAge at diagnosis is
C5 years. cP\ 0.05 two-tailed z test comparing the prevalence
estimate within each race/ethnicity/language group to the prevalence
estimate among NHW children
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If the lower prevalence estimates among older NHB and
Hispanic-Other children with relatively mild ASD is the
result of decreased identification, this might reflect less ac-
cess to services and limited acculturation among Hispanic-
Other children. Previous studies controlling for socioeco-
nomic status suggest that Hispanic immigrants are more
likely than non-immigrants to use folk remedies rather than
preventive care and mental health services [34, 35]. His-
panic immigrants also encounter cultural and language
barriers when seeking health care [35]. Previous research
also suggests that NHB and Hispanic children have less
access to mental health services than NHW children [36]
and that CSHCN living in non-English-primary-language-
households are less likely to have a medical home, a usual
source of care, and family-centered care than CSHCN from
English-primary-language-households [37, 38]. Finally, the
2007 American Academy of Pediatrics recommendations
for more aggressive ASD surveillance might have had a
larger impact on NHW children with better healthcare ac-
cess than NHB and Hispanic-Other children [39, 40].
Our finding that children with later ASD diagnoses were
more likely than children with earlier diagnoses to have
certain co-occurring health conditions was consistent with
another recent study [41]. Thus, in addition to access to
appropriate diagnostic services, some later diagnoses might
be attributable to an early masking effect by the symptoms
associated with other conditions.
Strengths of this study include the largest nationally
representative sample available to assess this emerging area
of research, and availability of data to examine both ASD
severity and co-occurring health conditions. We were still,
however, limited by small sample sizes within some sub-
groups. Thus, the presented estimates should be cautiously
interpreted. We present these estimates to provide a general
sense of the possible absolute variation in ASD diagnosis age
across race/ethnicity/language and ASD severity subgroups,
and for comparison of ASD prevalence rates with other
previously reported rates in US children [9]. Although some
point estimates had large RSEs, we note that most of the
relative comparisons were fairly stable.
This study also has several other potential limitations.
We lacked data on the specific reasons for a later ASD
diagnosis. Parent-reported ASD, ASD severity, and co-
occurring health conditions were not validated clinically;
however, previous studies suggest reliability of parent-re-
ported ASD [7] and comparability between ASD preva-
lence estimates from national surveys and ADDM [7, 17].
Nonetheless, although our findings are suggestive of under-
ascertainment of mild ASD in certain subgroups, we lacked
the data to definitely dismiss the possibility that some of
the differential between NHW and minority children was
due to over-reporting of mild ASD among NHW children.
Potential nonresponse bias is possible; however, a previous
study demonstrated this likely had little impact on the ASD
prevalence estimates [9]. Finally, relative to other US
surveys, the NS-CSHCN used a slightly different case
definition where parents had to endorse both special
healthcare needs and ASD; thus, some children with ASD
who were higher-functioning might have been missed.
Nonetheless, the ASD prevalence estimates from this study
based on 2009–2010 data falls as expected between pub-
lished estimates from 2007 and 2011 NSCH [9, 11].
Conclusion
The prevalence of CSHCN with diagnosed ASD remains
lower among NHB and non-English-speaking Hispanic
children than NHW children; the possibility of under-diag-
nosis of mild/moderate ASD among older children in these
two minority groups needs to be considered. The potential
for under-diagnosis is concerning since this will result in
delayed treatments. Previous studies suggest early inter-
vention is associated with improved outcomes [3–6].
Although there are less data for children with ASDs who are
considered high-functioning, recent reports suggest early
elementary school interventions have positive effects on
social functioning for this group as well [42]. The findings of
this study further support previous recommendations for
educating both parents and healthcare professionals about
early detection of ASD, and providing culturally competent
care [2, 8, 21, 23, 33]. Finally, the results illustrate that
studies examining all Hispanic children as a single subgroup
might be masking important within-group differences.
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